Navigation Links
RTS AviTag E. coli Biotinylation Kit, Linear Template; Linear template generation and in vitro protein mono-biotinylation system for use with RTS 100 expression reactions from Roche Applied Science

ProductsRTS AviTag E. coli Biotinylation Kit, Linear Template; Linear template generation and in vitro protein mono-biotinylation system for use with RTS 100 expression reactions from Roche Applied Science
Company Roche Applied Science
Item RTS AviTag E. coli Biotinylation Kit, Linear Template; Linear template generation and in vitro protein mono-biotinylation system for use with RTS 100 expression reactions
Price 
Description Roches RTS AviTag E. coli Biotinylation Kit, Linear Template is designed for use with high-yield RTS 100 E. coli expression kits. (Cat. No. 3 186 148, 3 186 156). The kit provides reagents to rapidly generate linear expression constructs by PCR containing and optimized control region for expression based on a combination of T7 RNA polymerase and prokaryotic cell lysate. Flexible positioning of AviTag [peptide sequence GLNDIFEAQKIEWHE] is possible. The linear constructs are ready for use as DNA templates in RTS 100 E. coli HY in vitro protein expression reactions without the need for purification.The expressed protein can be enzymatically mono-biotinylated by E. coli biotin protein ligase (BirA, E.C. 6.3.4.15). In addition to E. coli Bir A the kit supplies a substrate energy mixture, which is required for the biotinylation reaction.
Info Roche Applied ScienceRoche Applied Science
Roche Diagnostics Corporation
P.O. Box 50414
9115 Hague Road
Indianapolis, IN 46250-0414 USA




Call Roche Applied Science to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-346-8242
Customer Service: 800-262-1640
Tech Support: 800-262-4911
Fax Number: 800-428-2883
Web Site: http://www.roche-applied-science.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. RTS AviTag E. coli Biotinylation Kit, Plasmid; Cloning vector and in vitro protein mono-biotinylation system for use with RTS 100 and RTS 500 E. coli HY Kits from Roche Applied Science
2. LXQ High Throughput Linear Ion Trap from Thermo Scientific
3. LTQ XL Linear Ion Trap from Thermo Scientific
4. AXIMA-LNR Linear MALDI TOF from Shimadzu Biotech
5. Voice Coil Linear Scanning System from Physik Instrumente
6. LTQ XL Linear Ion Trap from Thermo Scientific
7. XRS Series Precision Linear Tables from Parker Hannifin Corporation
8. Blasticidin S HCl from Invitrogen
9. EBY100 S. cerevisiae Strain from Invitrogen
10. Anti-JIP 1 / 2 (SH3) Polyclonal Antibody, Unconjugated, Clone ZMD.177 from Invitrogen
11. SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
MOUSE ANTI HUMAN COMPLEMENT SC5B-9...
MOUSE ANTI SIMIAN VIRUS 5 Immunogen: Simian virus 5...
... Beagle serum is collected from fasted Beagle canines ... Available Anticoagulants: N-02: Citrate ... K2EDTA N-08: Potassium Oxalate N-10: ... N-05: ACD N-07: CPD ...
MOUSE ANTI BOVINE TROPONIN I...
Biology Products:
(Date:3/24/2015)...   NexID Biometrics LLC, whose spoof-mitigation technology ... announced the beginning of shipments of version 2.0 of ... company, based in Potsdam, N.Y. , ... which began here today at the Walter E. Washington ... its SDK boosts the accuracy rate range to 96.5 ...
(Date:3/23/2015)... OXFORD, Conn. , Mar. 23, 2015 NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, announces ... a new advertising campaign on CNBC television starting March 30 ... ads will commence airing in New York ... Executive Officer said: "We are excited about our new ad ...
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces its biometric ... news clip that aired this week on Washington ... In a segment "The Next Great Thing", host ... new way to pay, and ,a really big breakthrough in ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... April 10, 2013, New York, NY A dozen ... advancements in basic and clinical cancer research at this ... 2013. Progress in immunotherapy and epigenetics led the program ... therapy. "With new immunotherapy agents available ...
... at which a child with autism is diagnosed is ... or she exhibits, new research from the University of ... nonverbal communication and repetitive behaviors, were associated with earlier ... study in the April issue of the Journal ...
... Department of Energy,s (DOE) National Renewable Energy Laboratory (NREL) ... of real-world performance from solar facilities across the country. ... Performance and Reliability Clearinghouse (O-SPaRC) will give the private ... public capital. "The O-SPaRC dataset will provide the ...
Cached Biology News:Ludwig advancements in immunotherapy and epigenetics top scientific program at AACR 2In autism, age at diagnosis depends on specific symptoms 2
(Date:3/30/2015)... - A new national Labour Market Information (LMI) report ... of new graduates entering the biotech sector. The BioTalent ... New Grads in Biotech," is sponsored in part by ... and features data collected from new graduates that participated ... 2013 to 2015. Among the interesting trends ...
(Date:3/30/2015)... PARK, N.J. , March 30, 2015 /PRNewswire/ ... (PAMORA) under development by Shionogi & Co., Ltd., ... phase III study (COMPOSE I) for the treatment ... chronic non-cancer pain receiving opioid therapy. Study results ... daily) statistically significantly improved the frequency of spontaneous ...
(Date:3/29/2015)... March 29, 2015 Caris Life ... study data showing the presence of PD-1 ... cancer samples. Using Caris Molecular Intelligence®, the ... identified expression of programmed cell death protein-1 ... histology while its ligand (PD-L1) expression was ...
(Date:3/27/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... plan in accordance with Securities and Exchange Commission rule ... Neogen Corporation, is a minority owner of this entity ... Herbert does not have control of this entity, ... only for a portion of the shares owned by ...
Breaking Biology Technology:New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 3New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 4Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Neogen CEO adopts 10b5-1 Trading Plan 2